Introduction
NCI Special Notes
Funded T32 Grants
Submitting an Application
Peer Review Process
Frequently Asked Questions
NCI Staff Contacts
Introduction
The Ruth L. Kirschstein National Research Service Award (NRSA) uses the T32 grant mechanism to support Institutional Training Grants at eligible institutions to develop or enhance research training opportunities for individuals selected by the institution who are training for careers in biomedical and behavioral research. The NRSA may not be used to support studies leading to clinical degrees, such as the M.D., D.O., D.D.S., etc. Any individual with the skills, knowledge, and resources that are necessary to organize and implement a high quality research-training program is eligible to serve as the director of the research-training program. T32 grants can be supported for up to five years and are renewable.
Trainees must be citizens or non-citizen nationals of the United States, or
must have been lawfully admitted for permanent residency (i.e., possess a
currently valid Alien Registration Receipt Card I-551, or some other
legal verification of such status). Individuals on temporary or student
visas are not eligible for support by the NRSA. Whereas the
NIH NRSA Policy Guidelines allow funds for short-term or prebaccalaureate training, the NCI supports only predoctoral and postdoctoral training under this mechanism. Trainees are required to pursue their research training on a full-time basis, devoting at least 40 hours per week to the program. As specified in the NIH Revitalization Act of 1993, NRSA recipients incur a service payback obligation only during their first 12 months of postdoctoral support.
In general, the NRSA grant mechanism supports stipends (as defined by current Congressional legislation); tuition, fees and health insurance; trainees' training costs, including travel to scientific meetings; training-related expenses for costs such as staff salaries, equipment, etc.; and facilities and administrative allowance of 8 percent (previously called indirect costs).
PA-06-468 RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARDS FOR INSTITUTIONAL RESEARCH TRAINING GRANTS (T32)
 Back to Top
NCI Special Notes
NCI accepts T32 applications that are designed to prepare individuals for
careers in cancer research in the basic and clinical sciences, as well as in
prevention, control, behavioral and population-based sciences.
The NCI does not support short-term or prebaccalaureate training. Only
predoctoral and postdoctoral training are supported under this grant mechanism.
The main focus of NCI T32 grants is on preparing postdoctoral candidates for
careers in cancer research.
No more than 25 percent of the individuals supported on new T32 grants can be
predoctoral trainees. Exceptions should be directed to the NCI Cancer Training
Branch (see NCI Staff Contacts).
A minimum of 50 percent of the preceptors/mentors must have peer-reviewed
research support that is directly relevant to cancer research and 50 percent
that is cancer-related.
The NCI supports all of the traditional costs outlined in the official
T32 Program Announcement, however any applicant who is planning to
request more than $500,000 in direct costs in any year must receive prior
approval from an NCI Program Official in the Cancer Training Branch (see
NCI Staff Contacts).
In addition to the academic course work that trainees are expected to complete
as part of their traditional research-specialty training, they are expected to
be provided with a broad perspective (through additional course work, seminars,
or other means) of the research issues, approaches, concepts, and opportunities
in cancer research.
Under the NIH
Data Sharing Policy, grantees are expected to engage in a timely
release of final data sets that have been generated with NIH support for use by
other researchers, provide a Data Sharing Plan that will achieve this
objective, OR state why data sharing is not possible or appropriate. No Data
Sharing Plan is required for the T32 mechanism because it supports a training,
rather than a research grant. It supports stipends and other ancillary costs
for individual trainees, but it does not provide support for the generation of
research data, directly. With regard to the data generated by trainees working
in research environments funded by NIH research grants, it is the
responsibility of the institutions that are awarded these research grants to
share the data and provide acceptable Data Sharing Plans to the NIH as part of
the research application.
In 1996, the NCI developed and implemented a set of suggested tabular formats for the presentation of the large amount of data required for a T32 grant application. The purpose of these formats was to enhance the uniformity of the presentations of data in submitted T32 applications, thereby facilitating the review process; and to reduce the number of submitted applications with missing data. In the following years, a number of NIH institutes developed and implemented their own suggested sets of tabular formats for T32 grants. With a view to developing a common set of tabular formats for the data in T32 grant applications, in July, 2004 a Trans-NIH committee was convened to develop a common set of suggested tabular formats for T32 grant applications. The result of the activities of this committee was a set of suggested tabular formats which the NCI is adopting for use by their T32 applicants (NEW FORMATS). The NEW FORMATS tabular formats are also published on the National Institutes of General Medicine (NIGMS) website and can be accessed using the following link: (http://www.nigms.nih.gov/Training/NRSASuggestions.htm#sample_formats).
The provided tabular formats are only suggested and not required. The suggested formats also do not take into account all of the new requirements for diversity reporting. Applicants should refer to the section titled "Recruitment and Retention Plan to Enhance Diversity" using the Review Process hot link in the margin of this page for information or PA-06-468 (http://grants1.nih.gov/grants/guide/pa-files/PA-06-468.html) on diversity reporting requirements. Applicants are encouraged to at least refer to the suggested tabular formats to help ensure that they are providing all of the required information for a T32 grant application.
Back to Top
Funded T32 Grants
| Grant # | PI Name | Project Title | Org Name |
| 5T32CA088796-05 | AARONSON, STUART A | Postdoctoral Training Program in Cancer Biology | MOUNT SINAI SCHOOL OF MEDICINE OF NYU |
| 5T32CA078207-09 | AARONSON, STUART A | Training Program in Cancer Biology | MOUNT SINAI SCHOOL OF MEDICINE OF NYU |
| 5T32CA093258-05 | ALAVI, ABASS | Training in Cancer Imaging with Novel Techniques | UNIVERSITY OF PENNSYLVANIA |
| 2T32CA009149-31A1 | ALLISON, JAMES P | Immunology Research Training | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA009515-23 | APPELBAUM, FREDERICK R | TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION | UNIVERSITY OF WASHINGTON |
| 5T32CA078136-10 | ARTEAGA, CARLOS L | Training Program in Breast Cancer Research | VANDERBILT UNIVERSITY |
| 2T32CA093247-06 | Ayer, Donald E | Multidisciplinary Cancer Research Training Program | UNIVERSITY OF UTAH |
| 2T32CA009503-21A1 | BAER, RICHARD | Cancer Biology Training Program | COLUMBIA UNIVERSITY HEALTH SCIENCES |
| 2T32CA009207-31 | BAJORIN, DEAN | Cancer Chemotherapy Training Program | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA009207-30 | Bajorin, Dean | Cancer Chemotherapy Training Program | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 2T32CA081156-06A1 | Balk, steven p | Training Grant in Cancer Biology | BETH ISRAEL DEACONESS MEDICAL CENTER |
| 5T32CA113263-02 | BARTLETT, DAVID L | Postdoctoral Research Training in Biotherapy of Cancer | UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
| 5T32CA009634-15 | BERGSTROM, Donald E. | Training in Drug and Carcinogen-DNA Interactions | PURDUE UNIVERSITY WEST LAFAYETTE |
| 2T32CA009351-29 | BERNSTEIN, IRWIN D | Pediaric Oncology Research Training Program | FRED HUTCHINSON CANCER RESEARCH CENTER |
| 5T32CA009043-33 | BISHOP, J MICHAEL | The Molecular Analysis of Tumor Viruses | UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
| 2T32CA091078-06 | BLAND, KIRBY I | Research Training Program in Surgical Oncology | UNIVERSITY OF ALABAMA AT BIRMINGHAM |
| 5T32CA009213-30 | BOWDEN, GEORGE Timothy | CANCER BIOLOGY TRAINING GRANT | UNIVERSITY OF ARIZONA |
| 2T32CA009501-21 | BRENNAN, MURRAY F | SURGICAL ONCOLOGY RESEARCH TRAINING GRANT | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA009528-22 | BROACH, JAMES R. | ONCOLOGY: Molecular Basis of Cancer | PRINCETON UNIVERSITY |
| 5T32CA009615-18 | BRODEUR, GARRETT M | Cancer center research training program | UNIVERSITY OF PENNSYLVANIA |
| 5T32CA009640-18 | BUCHANAN, GEORGE R | Pediatric Hematology and Oncology Research | UNIVERSITY OF TEXAS SW MED CTR/DALLAS |
| 5T32CA009678-14 | BUCHBERG, Arthur M. | Training Program in Molecular Genetics of Cancer | THOMAS JEFFERSON UNIVERSITY |
| 5T32CA009338-29 | CALIGIURI, MICHAEL A | Oncology Training Grant | OHIO STATE UNIVERSITY |
| 5T32CA106493-03 | Cance, William G | Surgical Oncology Research Training | UNIVERSITY OF FLORIDA |
| 5T32CA070083-10 | CANTOR, HARVEY I | POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY | DANA-FARBER CANCER INSTITUTE |
| 5T32CA009582-20 | CARPENTER, GRAHAM F | Biochemical and Chemical Training for Cancer Research | VANDERBILT UNIVERSITY |
| 5T32CA119931-02 | CASSILETH, BARRIE R | Integrative Oncology Research Training Program at MSKCC | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA009672-17 | CHANG, ALFRED E | University of Michigan Surgical Oncology Research Training Program | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| 5T32CA009085-33 | CHENG, YUNG-CHI | Biochemical Aspects of Chemotherapy | YALE UNIVERSITY |
| 5T32CA060441-15 | CIVIN, CURT I | Lab Research Training in Pediatric Oncology-Hematology | JOHNS HOPKINS UNIVERSITY |
| 5T32CA009151-33 | CLEARY, MICHAEL L | Postdoctoral Training in Tumor Biology | STANFORD UNIVERSITY |
| 5T32CA059367-13 | CLOUSE, MELVIN E | BIDMC Research Training Grant in Cancer Radiology | BETH ISRAEL DEACONESS MEDICAL CENTER |
| 5T32CA009657-17 | COOPER, JONATHAN A. | Chromosome Metabolism and Cancer Training Grant | FRED HUTCHINSON CANCER RESEARCH CENTER |
| 5T32CA060395-12 | Courtney, Richard J | Viruses and Cancer | PENNSYLVANIA STATE UNIV HERSHEY MED CTR |
| 5T32CA009307-30 | CRAWFORD, JEFFREY | Research Training in Cancer Biology and Therapy | DUKE UNIVERSITY |
| 5T32CA009111-30 | Cullen, Bryan | Viral Oncology Training Grant | DUKE UNIVERSITY |
| 5T32CA075930-09 | Curiel, David T | Cancer Gene Therapy Training Program | UNIVERSITY OF ALABAMA AT BIRMINGHAM |
| 5T32CA103652-04 | DALY, JOHN M | Training Program in Surgical Oncology | TEMPLE UNIVERSITY |
| 5T32CA106196-04 | DE LA CHAPELLE, ALBERT | Postdoctoral Training in Cancer Genetics | OHIO STATE UNIVERSITY |
| 2T32CA009673-31 | de Lange, Titia | Mechanisms of cell regulation and transformation | ROCKEFELLER UNIVERSITY |
| 5T32CA009659-15 | DeClerck, Yves A | TRAINING IN BASIC RESEARCH IN ONCOLOGY | CHILDREN'S HOSPITAL LOS ANGELES |
| 5T32CA009206-29 | DeLuca, Paul M | U.W. Radiological Sciences Training Program | UNIVERSITY OF WISCONSIN MADISON |
| 5T32CA009078-33 | Demple, Bruce F. | Radiation Biology Training Program | HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) |
| 5T32CA071341-12 | DER, CHANNING J | Cancer Cell Biology Training Program | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL |
| 5T32CA060396-14 | DISAIA, PHILIP J | Gynecologic Oncology Fellowship Program | UNIVERSITY OF CALIFORNIA IRVINE |
| 5T32CA059366-14 | DISTELHORST, CLARK W | Research Oncology Training Grant | CASE WESTERN RESERVE UNIVERSITY |
| 1T32CA115308-01A1 | DJEU, JULIE Y | Tumor Immunology Training Program | H. LEE MOFFITT CANCER CTR & RES INST |
| 5T32CA009523-23 | DONOGHUE, DANIEL J | Biochemistry of Growth Regulation and Oncogenesis | UNIVERSITY OF CALIFORNIA SAN DIEGO |
| 5T32CA009120-32 | Dubinett, Steven M. | Tumor Immunology Institutional Training Grant | UNIVERSITY OF CALIFORNIA LOS ANGELES |
| 2T32CA009658-16 | EASTMAN, ALAN R | Cancer Biology and Molecular Therapeutics | DARTMOUTH COLLEGE |
| 5T32CA009621-19 | EBERLEIN, TIMOTHY J | Surgical Oncology Training Grant | WASHINGTON UNIVERSITY |
| 5T32CA079446-08 | ECKHARDT, S GAIL | Training in Pharmacology of Antineoplastic Agents | UNIVERSITY OF COLORADO DENVER/HSC AURORA |
| 5T32CA075924-10 | EDGINGTON, THOMAS S | VASCULAR BIOLOGY IN CANCER | SCRIPPS RESEARCH INSTITUTE |
| 5T32CA009683-15 | EISENLOHR, LAURENCE C | TRAINING PROGRAM IN CANCER IMMUNOLOGY | THOMAS JEFFERSON UNIVERSITY |
| 5T32CA009599-19 | ELLIS, LEE M. | Training of Academic Surgical Oncologists | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 5T32CA009054-30 | FAN, HUNG Y | A TRAINING PROGRAM IN CARCINOGENESIS | UNIVERSITY OF CALIFORNIA IRVINE |
| 5T32CA067754-13 | FARQUHAR, MARILYN G | Graduate Training in Cancer Cell Biology | UNIVERSITY OF CALIFORNIA SAN DIEGO |
| 5T32CA082084-09 | FINN, OLIVERA J | Training/Cellular/Molecular Mechanisms/Tumor Rejection | UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
| 2T32CA009041-31A2 | FIRESTONE, GARY L | REGULATORY BIOLOGY OF CANCER AND GROWTH CONTROL | UNIVERSITY OF CALIFORNIA BERKELEY |
| 5T32CA009056-32 | FOX, CHARLES F | Tumor Cell Biology Training Program | UNIVERSITY OF CALIFORNIA LOS ANGELES |
| 2T32CA093240-06 | Freeman, MICHAEL L | Training Grant In Radiation Biology | VANDERBILT UNIVERSITY |
| 5T32CA074736-08 | FRIEDMAN, HENRY S | Research Training In Neuro-Oncology | DUKE UNIVERSITY |
| 5T32CA090221-05 | FUQUA, SUZANNE A | Translational Breast Cancer Research Training Program | BAYLOR COLLEGE OF MEDICINE |
| 2T32CA067751-11A1 | GABRIELSON, EDWARD W | Training Program in the Pathobiology of Cancer | JOHNS HOPKINS UNIVERSITY |
| 5T32CA082086-08 | GARCEA, ROBERT L | Postgraduate Training in Pediatric Oncology | UNIVERSITY OF COLORADO DENVER/HSC AURORA |
| 5T32CA101642-03 | GERSHENSON, DAVID M | Training of Academic Gynecologic Oncologists | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 1T32CA121940-01A1 | GIACCIA, AMATO | Postdoctoral Training in the Radiation Sciences | STANFORD UNIVERSITY |
| 2T32CA009302-31 | GIACCIA, AMATO J | Cancer Etiology, Prevention, Detection and Diagnosis | STANFORD UNIVERSITY |
| 5T32CA009243-30 | Gibson, D. Wade | Training in Anti-Cancer Drug Development | JOHNS HOPKINS UNIVERSITY |
| 5T32CA093283-05 | Gimotty, Phyllis A | Cancer Biostatistics Training Grant | UNIVERSITY OF PENNSYLVANIA |
| 2T32CA085159-06A2 | GINDER, GORDON D | Postdoctoral Training Program in Cancer Biology | VIRGINIA COMMONWEALTH UNIVERSITY |
| 5T32CA009695-15 | GLAZER, GARY M | Advanced Techniques for Cancer Imaging | STANFORD UNIVERSITY |
| 5T32CA009259-23 | GLAZER, PETER M | Research Training: Radiation Therapy, Biology, Physics | YALE UNIVERSITY |
| 5T32CA106183-04 | GOLDENRING, JAMES R | Surgical Oncology Training Grant | VANDERBILT UNIVERSITY |
| 5T32CA009072-32 | GOODRICH, DAVID W | Drug Development and Cancer Treatments | ROSWELL PARK CANCER INSTITUTE CORP |
| 5T32CA060397-13 | Grandis, Jennifer R | Postdoctoral Research Training in Head and Neck Oncology | UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
| 2T32CA009560-21A1 | GREEN, KATHLEEN J | Carcinogenesis Training Program | NORTHWESTERN UNIVERSITY |
| 5T32CA009594-19 | Greene, Geoffrey | Graduate Training Program in Cancer Biology | UNIVERSITY OF CHICAGO |
| 5T32CA101968-05 | GREENE, MARK I | Training in Cancer Immunopathobiology | UNIVERSITY OF PENNSYLVANIA |
| 5T32CA079449-08 | GROSSMAN, H. BARTON | Training of Academic Urologic Oncologists | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 5T32CA009574-20 | GROSSMAN, STUART A | Research Training in Neuro-Oncology | JOHNS HOPKINS UNIVERSITY |
| 5T32CA062948-13 | GUDAS, LORRAINE J | CANCER PHARMACOLOGY | WEILL MEDICAL COLLEGE OF CORNELL UNIV |
| 5T32CA009176-30 | HEARING, PATRICK | Cancer Biochemistry and Cell Biology | STATE UNIVERSITY NEW YORK STONY BROOK |
| 5T32CA009681-15 | HOFFMANN, F. M | Molecular Mechs.Regulating Cancer Cell Proliferation | UNIVERSITY OF WISCONSIN MADISON |
| 5T32CA009666-13 | HONG, WAUN K | Research Training in Academic Medical Oncology | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 5T32CA121938-02 | HOWELL, STEPHEN B | UCSD Cancer Center Training Program in Drug Development | UNIVERSITY OF CALIFORNIA SAN DIEGO |
| 5T32CA009563-19 | Hudig, Dorothy | Cell and Molecular Cancer Research Training in Nevada | UNIVERSITY OF NEVADA RENO |
| 5T32CA106209-04 | IBRAHIM, JOSEPH G | Biostatistics for Research in Genomics and Cancer | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL |
| 5T32CA009535-22 | IGLEHART, JAMES D | Advanced Training in Surgical Oncology | BRIGHAM AND WOMEN'S HOSPITAL |
| 2T32CA009676-16 | IMPERIALE, MICHAEL J | Cancer Biology Training Program | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| 5T32CA119930-02 | Jackson, Edward F | Medical Physics Training Grant for Image-Guided Therapy Research | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 5T32CA073479-10 | Jain, Rakesh K. | Training Program in Pathophysiology of Solid Tumors | MASSACHUSETTS GENERAL HOSPITAL |
| 5T32CA108456-02 | JOHNSON, CANDACE S | Postdoctoral Research Training in Surgical Oncology | ROSWELL PARK CANCER INSTITUTE CORP |
| 5T32CA009492-23 | Johnson, Carl Anderson | Cancer Control and Epidemiology Research Training Grant | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 1T32CA119910-01A1 | JOHNSON, DAVID H | Vanderbilt Training Program in Academic Cancer Research | VANDERBILT UNIVERSITY |
| 5T32CA009320-23 | JONES, PETER A | TRAINING PROGRAM IN VIRAL AND CHEMICAL CARCINOGENESIS | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 5T32CA077109-08 | KAMPS, MARK P | Molecular Pathology of Cancer Training Grant | UNIVERSITY OF CALIFORNIA SAN DIEGO |
| 2T32CA070089-11 | KASTAN, MICHAEL B | Laboratory Training for Clinical Oncologists | ST. JUDE CHILDREN'S RESEARCH HOSPITAL |
| 5T32CA009512-22 | KELLY, THOMAS J | Clinical Scholars Biomedical Research Training Program | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 2T32CA009677-16 | KENNEDY, ANN R | Radiation biology training grant | UNIVERSITY OF PENNSYLVANIA |
| 5T32CA059268-12 | Khan, Sohaib A. | Regulation of Cellular Growth and Differentiation | UNIVERSITY OF CINCINNATI |
| 5T32CA009031-31 | KIEFF, ELLIOTT D | VIRUS-HOST INTERACTIONS IN CANCER | HARVARD UNIVERSITY (MEDICAL SCHOOL) |
| 5T32CA106195-04 | KULESZ-MARTIN, MOLLY F | Training in Molecular Basis of Skin Pathobiology | OREGON HEALTH & SCIENCE UNIVERSITY |
| 5T32CA108459-02 | Kung, Hsing-Jien | Training Program in Oncogenic Signals and Chromosome Biology | UNIVERSITY OF CALIFORNIA DAVIS |
| 5T32CA009363-25 | Land, Hartmut | Cancer Center Training-Experimental Therapy Models | UNIVERSITY OF ROCHESTER |
| 5T32CA099946-05 | LATTIME, EDMUND C. | Training Program in Translational Research in Cancer | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH |
| 2T32CA085183-06A1 | LEE, KELVIN | Multidisciplinary approaches to tumor immunology | ROSWELL PARK CANCER INSTITUTE CORP |
| 1T32CA113265-01A2 | Lee, Wen-Hwa | Translational Research in Cancer Genomic Medicine | UNIVERSITY OF CALIFORNIA IRVINE |
| 5T32CA009287-30 | LEVY, RONALD | TRAINING PROGRAM IN INVESTIGATIVE ONCOLOGY | STANFORD UNIVERSITY |
| 5T32CA061801-12 | LING, CLIFTON C | Training in Radiation Oncology | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA080416-09 | Linial, Maxine L | Interdisciplinary Tranining in Cancer Research | UNIVERSITY OF WASHINGTON |
| 5T32CA009229-30 | Linial, Maxine L | Graduate and Postdoctoral Training in Viral Oncology | UNIVERSITY OF WASHINGTON |
| 5T32CA108455-03 | LIU, LEROY F | Training in Cancer Pharmacology | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH |
| 5T32CA009216-27 | LOUIS, DAVID N. | Molecular Immunology and Tumor Biology | MASSACHUSETTS GENERAL HOSPITAL |
| 5T32CA009299-29 | Lozano, Guillermina | Training Program in Molecular Genetics of Cancer | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 2T32CA093245-06 | LYERLY, HERBERT K | Translational Research in Surgical Oncology | DUKE UNIVERSITY |
| 5T32CA101690-05 | MAGUN, BRUCE E. | Training Program in Cancer Cell Biology | OREGON HEALTH & SCIENCE UNIVERSITY |
| 5T32CA090217-07 | MAHVI, DAVID M | Surgical Oncology Research Training Program | UNIVERSITY OF WISCONSIN MADISON |
| 2T32CA009171-31A2 | MARMORSTEIN, RONEN | Training Program in Basic Cancer Research | WISTAR INSTITUTE |
| 2T32CA009531-21 | Matherly, Larry H | Training Program in the Biology of Cancer | WAYNE STATE UNIVERSITY |
| 5T32CA009126-30 | MAY, W. Stratford | Training Grant in Cancer Biology | UNIVERSITY OF FLORIDA |
| 5T32CA009172-33 | MAYER, ROBERT J | Graduate Training in Cancer Research | DANA-FARBER CANCER INSTITUTE |
| 5T32CA009598-18 | McINTYRE, BRADLEY W | Training Program in Cancer Immunobiology | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 5T32CA009110-31 | MCMACKEN, ROGER L | Training in Areas Fundamental to Cancer Research | JOHNS HOPKINS UNIVERSITY |
| 1T32CA113277-01A2 | MIKKELSEN, ROSS B | Training in Radiation Oncology Translational Research | VIRGINIA COMMONWEALTH UNIVERSITY |
| 5T32CA009454-21 | MUGGIA, FRANCO M | Research Training in Cancer Medicine | NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
| 5T32CA060374-12 | MYERS, JEFFREY N | Training of Academic Head and Neck Surgical Oncologist | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR |
| 5T32CA009173-33 | NATHENSON, STANLEY G | Immunology and Immunooncology Training Program | YESHIVA UNIVERSITY |
| 5T32CA009071-27 | NELSON, WILLIAM G | Molecular Targets for Cancer Detection and Treatment | JOHNS HOPKINS UNIVERSITY |
| 5T32CA009529-20 | NEUGUT, ALFRED I | Cancer Epidemiology/Biostastistics/Environmental Health | COLUMBIA UNIVERSITY HEALTH SCIENCES |
| 2T32CA009566-21 | Olopade, Olufunmilayo I | Basic Medical Oncology Research Training in Medical Oncology | UNIVERSITY OF CHICAGO |
| 5T32CA009330-27 | OLSHAN, ANDREW F | Training Grant in Cancer Epidemiology | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL |
| 5T32CA009461-24 | OSTROFF, JAMIE S | Psychosocial Palliative and Community Research in Cancer | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA009156-33 | PAGANO, JOSEPH S | Basic Mechanisms of Viral and Chemical Carcinogenesis | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL |
| 2T32CA009109-31A1 | PARSONS, SARAH J | Cancer Research Training in Molecular Biology | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE |
| 5T32CA009140-33 | PATERSON, YVONNE J | Immunobiology of normal and neoplastic lymphocytes | UNIVERSITY OF PENNSYLVANIA |
| 5T32CA009682-15 | PAULI, BENDICHT U | Training in Molecular and Cell Biology of Cancer | CORNELL UNIVERSITY ITHACA |
| 5T32CA009161-33 | PELLICER, ANGEL G. | Training Program in Molecular Oncology and Immunology | NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
| 2T32CA070085-11 | PELLING, JILL C | Training Program in Signal Transduction and Cancer | NORTHWESTERN UNIVERSITY |
| 5T32CA009314-25 | Platz, Elizabeth A. | Institutional Research Cancer Epidemiology Fellowship | JOHNS HOPKINS UNIVERSITY |
| 5T32CA115303-02 | Poplack, David | Pediatric Oncology Research Training Program | BAYLOR COLLEGE OF MEDICINE |
| 5T32CA113275-02 | RATNER, LEE | Molecular Oncology Training Grant | WASHINGTON UNIVERSITY |
| 2T32CA009179-31A1 | RAULET, DAVID H | Molecular Immunology and Tumor Biology | UNIVERSITY OF CALIFORNIA BERKELEY |
| 5T32CA009686-11 | Riegel, Anna T. | Training Grant in Tumor Biology | GEORGETOWN UNIVERSITY |
| 5T32CA009476-18 | RIZZINO, ARNOLD A | Cancer Biology Training Program | UNIVERSITY OF NEBRASKA MEDICAL CENTER |
| 5T32CA113267-03 | ROBBINS, MICHAEL E.C. | Training Program in Translational Radiation Oncology | WAKE FOREST UNIVERSITY HEALTH SCIENCES |
| 5T32CA115299-02 | ROBERTSON, ERLE S | Training in Tumor Virology | UNIVERSITY OF PENNSYLVANIA |
| 5T32CA111198-03 | ROMAN, ANN | Cancer Biology Training Program | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS |
| 1T32CA121949-01A2 | RONAI, ZE'EV A | Trans-disciplinary Postdoctoral Training in Cancer Biology | BURNHAM INSTITUTE FOR MEDICAL RESEARCH |
| 5T32CA079447-09 | ROSEN, STEVEN T | Clinical Oncology Research Training Program | NORTHWESTERN UNIVERSITY |
| 5T32CA099936-04 | Ross, Julie A | Pediatric Cancer Epidemiology Training Grant | UNIVERSITY OF MINNESOTA TWIN CITIES |
| 5T32CA009385-25 | RULEY, H. E. | Viruses, Nucleic Acids and Cancer | VANDERBILT UNIVERSITY |
| 5T32CA082088-08 | SCARDINO, PETER T | Urologic Oncology Research Training Grant | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 5T32CA065441-10 | Schaffhausen, Brian | Interdisciplinary Training Program in Cancer Genetics | TUFTS UNIVERSITY BOSTON |
| 5T32CA009547-22 | SCHREIBER, ROBERT D. | Training in Cancer Biology | WASHINGTON UNIVERSITY |
| 2T32CA009685-16 | SHAH, JATIN P | Head and Neck Training Program in Surgical Oncology | SLOAN-KETTERING INSTITUTE FOR CANCER RES |
| 1T32CA128583-01 | SHANNON, KEVIN M | Research Training in Childhood Cancer | UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
| 1T32CA124334-01A1 | SHAY, JERRY W | Cancer Biology Training Grant | UNIVERSITY OF TEXAS SW MED CTR/DALLAS |
| 5T32CA009138-33 | SHIMIZU, YOJI | CANCER BIOLOGY TRAINING GRANT | UNIVERSITY OF MINNESOTA TWIN CITIES |
| 5T32CA009035-32 | SKALKA, ANNA M | Training Program in Cancer Research | INSTITUTE FOR CANCER RESEARCH |
| 1T32CA119929-01A1 | SLINGERLAND, JOYCE | Training in Translational Breast Cancer Research | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE |
| 5T32CA009502-20 | SORENSEN, ALMA GREGORY | Nuclear Magnetic Resonance | MASSACHUSETTS GENERAL HOSPITAL |
| 5T32CA117846-02 | STAMBROOK, PETER J | Training Program in Cancer Therapeutics | UNIVERSITY OF CINCINNATI |
| 5T32CA009001-32 | Stampfer, Meir J. | Program for Training in Cancer Epidemiology | HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) |
| 5T32CA009361-27 | STILES, CHARLES D | Tumor Cell Biology Training Program | DANA-FARBER CANCER INSTITUTE |
| 2T32CA009679-16 | STROM, BRIAN L | Cancer Clinical Epidemiology Training Grant | UNIVERSITY OF PENNSYLVANIA |
| 2T32CA009135-31A2 | SUGDEN, BILL | Training in Cancer Biology | UNIVERSITY OF WISCONSIN MADISON |
| 2T32CA071345-11 | TANABE, KENNETH K | Training Program in Cancer Biology | MASSACHUSETTS GENERAL HOSPITAL |
| 2T32CA083654-06 | TAYLOR, JEREMY M | Biostatistical Training in Cancer Research | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| 5T32CA119945-02 | TEW, KENNETH D. | TRAINING IN CANCER THERAPEUTICS | MEDICAL UNIVERSITY OF SOUTH CAROLINA |
| 5T32CA117834-02 | THOMPSON, E B | Multidisciplinary Training in Cancer Research | UNIVERSITY OF TEXAS MEDICAL BR GALVESTON |
| 2T32CA009357-26 | TODD, ROBERT F | Oncology Research Training Grant | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| 5T32CA079448-08 | TORTI, FRANK M | Training Program in Cancer Biology | WAKE FOREST UNIVERSITY HEALTH SCIENCES |
| 5T32CA009429-25 | TSICHLIS, PHILIP N | Research Training in Oncology | NEW ENGLAND MEDICAL CENTER HOSPITALS |
| 5T32CA009236-30 | ULLRICH, ROBERT L | Radiological Health Sciences Basic to Cancer Research | COLORADO STATE UNIVERSITY-FORT COLLINS |
| 2T32CA009168-31A1 | VAUGHAN, THOMAS | Cancer Epidemiology and Biostatistics Training | UNIVERSITY OF WASHINGTON |
| 5T32CA009370-26 | WAHL, GEOFFREY M. | Cell Regulation, Differentiation and Cancer | SALK INSTITUTE FOR BIOLOGICAL STUDIES |
| 5T32CA059365-13 | Wang, Xiao-Fan | Cancer Biology Training Grant | DUKE UNIVERSITY |
| 5T32CA079443-07 | WEISSLEDER, RALPH | Training grant in molecular imaging research | MASSACHUSETTS GENERAL HOSPITAL |
| 5T32CA108462-04 | WERB, ZENA | Molecular and Cellular Mechanisms in Cancer | UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
| 5T32CA009614-18 | WILDING, GEORGE | Physician Scientist Training in Cancer Medicine | UNIVERSITY OF WISCONSIN MADISON |
| 5T32CA009537-20 | WILSON, CHRISTOPHER B | Basic and Cancer Immunology | UNIVERSITY OF WASHINGTON |
| 5T32CA072319-10 | Zeisel, Steven H | Nutritional Biochemistry and Epidemiology of Cancer | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL |
| 5T32CA009337-27 | ZELEN, MARVIN | Biostatistics/Epidemiology Training Grant in Biostatistics | HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) |
| 5T32CA009142-28 | Zhang, Zuo-Feng | Cancer Epidemiology Training Program | UNIVERSITY OF CALIFORNIA LOS ANGELES |
Back to Top
Submitting an Application
Notice: Beginning *September 25, 2007, all T32 applications are required to be submitted electronically. To be prepared and informed about electronic submission of applications, please visit http://era.nih.gov/ElectronicReceipt/ (* This date is subject to be delayed )
Applications for the T32 Award are submitted using the
PHS 398 Form (Revised
9/2004). The applicant should download the PHS instructions files and the
Institutional National Research Service Award (NRSA) form files. Refer to
Section IV of the instructions titled "Instructions For Preparing An NRSA
Application". It is suggested that you print, if possible, the pages of
PHS 398
Form (Revised 9/2004) and carefully review all pages, especially the section
titled "NOTABLE CHANGES MADE TO PHS 398. This section contains information to
facilitate the completion of your application.
In 1996, the NCI developed and implemented a set of suggested tabular formats (OLD FORMATS (Word for Windows or Adobe PDF)) for the presentation of the large amount of data required for a T32 grant application. The purpose of these formats was to enhance the uniformity of the presentations of data in submitted T32 applications, thereby facilitating the review process; and to reduce the number of submitted applications with missing data. In the following years, a number of NIH institutes developed and implemented their own suggested sets of tabular formats for T32 grants. With a view to developing a common set of tabular formats for the data in T32 grant applications, in July, 2004 a Trans-NIH committee was convened to develop a common set of suggested tabular formats for T32 grant applications. The result of the activities of this committee was a set of suggested tabular formats which the NCI is adopting for use by their T32 applicants. Currently these tabular formats are being presented as an option (NEW FORMATS) to the prior formats (OLD FORMATS (Word for Windows or Adobe PDF)) for T32 applicants submitting applications for the January 25, 2007 receipt date; and can be accessed using the following link (NEW FORMATS) After this date, the NEW FORMATS tabular formats will replace the current set of tabular formats. The NEW FORMATS tabular formats are also published on the National Institutes of General Medicine (NIGMS) website and can be accessed using the following link:
(http://www.nigms.nih.gov/Training/Application/NRSASuggestions.htm#sample_formats).
The provided tabular formats are only suggested and not required. Applicants may still use either of the currently suggested tabular formats, or any other format of their choice. However, applicants are encouraged to at least refer to the suggested tabular formats to help ensure that they are providing all of the required information for a T32 grant application.
For all competing T32 grants that have been funded and all non-competing
renewal T32 grants, specialized forms are required that document the
appointment and termination of all trainees who receive support. These forms
are as follows:
-
The Statement of
Appointment (PHS 2271) must be completed for all trainees newly
appointed or reappointed for support form a T32 grant.
-
The Termination Notice
(PHS 416-7) must be completed for all trainees whose support from the
T32 grant has ended.
-
The Payback Agreement
(PHS 6031) signed by the trainee in agreement to abide by the payback
provisions for National Research Service Awards.
It is imperative that when filling out appointment, reappointment and
termination forms that you use the correct stipend levels for the Fiscal Year
that your grant was awarded. Otherwise, you will have to redo the forms. For
your convenience, the NCI provides the correct stipend levels to the year,
month and day for the Fiscal Years currently in effect:
FY2006 Stipend Levels (Excel
Spreadsheet) (PDF
File)
FY2005 Stipend Levels (Excel
Spreadsheet) (PDF
File)
FY2004 Stipend Levels (Excel
Spreadsheet) (PDF
File)
FY2003 Stipend Levels (Excel
Spreadsheet) (PDF
File)
| | Application Receipt Date: New, Renewal*, Revision*, and Resubmission* | Initial Review Date | Council Review Date | Earliest Possible Start Date ** |
| Receipt Cycle 1 | January 25 | June/July | September/ October | December |
| Receipt Cycle 2 | May 25 | October/November | January/ February | April |
| Receipt Cycle 3 | September 25 | February/March | May/June | July |
*The move to electronic applications also has brought a change in terminology. The new Grants.gov terminology corresponds to traditional NIH terms as follows:
|
Traditional Terminology
|  | Grants.gov Terminology |
| New | | New |
| Revised or Amended application | | Resubmission |
| Competing Continuation | | Renewal |
| Continuation | | Progress Report |
| Revision | | Competing Supplement |
If the application receipt date falls on a weekend, the application must be postmarked by the application receipt date and received at the Center for Scientific Review (CSR) by the following Monday.
If the application receipt date falls on a holiday, (but not on a weekend), the application must be postmarked by the application receipt date and received at CSR by the following day.
** Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Back to Top
Peer Review Process
Upon receipt, competing applications will be reviewed both by the Center for
Scientific Review (CSR) and the National Cancer Institute (NCI) for
completeness and for conformance to all eligibility requirements and special
provisions and requirements. Incomplete applications will be returned to the
applicant without further consideration.
Those applications judged to be complete and eligible will be evaluated,
according to the review criteria listed in the
T32 Program Announcement, by a peer review group convened by the
Division of Extramural Activities of the NCI. Applications will receive a
second level review by the National Cancer Advisory Board (NCAB) to determine
if the application meets the broad program needs and priorities of the NCI and
the National Cancer Program.
The following review criteria are a combination of those listed in the Program
Announcement and those used by the NCI.
These review criteria enter into the priority score:
PROGRAM CHARACTERISTICS: The reviewers will evaluate the distinctive
nature of the training program relative to other training programs in the
institution utilizing the same mentors and serving the same organizational
units (e.g., departments), the quality of the training experiences that fit the
program aims, and the overall content of the program that characterizes it as a
cancer training program. They will also assess the likelihood that the program
will achieve its proposed training goals. For competing continuation
applications, they will evaluate the track record of the training
program in achieving its objectives.
For postdoctoral trainees: The reviewers will evaluate the
objectives, design and direction of the research training program; and the
seminars/invited lectures providing all trainees with a perspective on the
issues, approaches, concepts and opportunities in cancer basic science,
patient-oriented research and in cancer prevention and control.
For predoctoral trainees: The reviewers will evaluate the
admission standards for predoctoral students and the quality of the objectives,
design and direction of the research training program; formal curriculum/course
work and its suitability for training pre-doctoral level candidates; and the
seminars/invited lectures providing all trainees with a perspective on the
issues, approaches, concepts and opportunities in cancer basic science,
patient-oriented research and in cancer prevention and control.
PROGRAM DIRECTOR: The reviewers will evaluate the qualifications of the
Program Director to provide the administrative and scientific leadership of a cancer
training program.
PARTICIPATING FACULTY: The reviewers will evaluate the cancer research
focus of the faculty (at least 50 percent of faculty must have independent
research support directly relevant to cancer research, and the remaining
faculty must have research support reasonably related to cancer, and should be
reflected in the proportion of faculty identified as mentors); quality of the
research experience and productivity of the faculty who will serve as mentors,
and their individual success in obtaining independent research support. They
will also assess the availability of each mentor to provide research training,
track record of the faculty in training individuals including the research
productivity of past trainees and their success in achieving independence,
faculty stability and cooperation, and the appropriateness of the trainee to
faculty ratio. For competing renewal applications, the reviewers will
also evaluate the track record of the mentors in training appointees who have
continued in successful research careers.
TRAINEES: The reviewers will assess the quality and adequacy of the
recruitment and selection process for trainees, the adequacy of the pool size
of high quality trainees, and the trainees' track record of degrees attained
and the current career status of past trainees (if available). For competing
renewal applications, they will also assess the track record of
filling awarded trainee slots with high quality trainees during the prior
funding period, the evenness of distribution of trainee appointments among the
training program mentors, the success in recruitment of underrepresented
minorities, and the track record of the training program in supporting
individuals with M.D. or other health professional degrees for at least two
years.
TRAINING RESOURCES AND ENVIRONMENT: The reviewers will assess the
availability and adequacy of the necessary facilities, equipment, and space;
the quality and cooperation of other basic and clinical departments and
programs that might be available to support program goals; and the strength of
the institutional support of the proposed training.
These additional criteria do not enter into the priority score:
BUDGET: The reviewers will comment on whether the budget can accommodate
the proposed number of trainees. -
RECRUITMENT AND RETENTION PLAN TO ENHANCE DIVERSITY:
Applicants must submit a plan for recruiting trainees from both outside and inside of their sponsoring institutions. This plan should describe any planned recruitment and outreach activities to increase the depth and diversity of the applicant pool, including those individuals underrepresented in the current scientific research workforce in the area of proposed research training. The plan must be specific to the proposed training program; reference to an institutional plan is not sufficient. Please follow the following link from the National Heart, Lung and Blood Institute for suggested elements to be included in a plan for recruiting individuals from underrepresented racial/ethnic groups: http://www.nhlbi.nih.gov/funding/policies/t32/t32recruitment.htm
Competing continuation and non-competing applications must include a detailed account of experiences in recruiting individuals from underrepresented groups during the previous funding period. Information must be included on successful and unsuccessful recruitment strategies including aggregate information on the distribution of:
- Predoctorates or postdoctorates who applied for admission or positions within the department(s)/programs(s) relative to the training grant,
- Predoctorates or postdoctorates who were offered admission to or a position within the department(s)/program(s),
- Predoctorates or postdoctorates actually enrolled in the academic program relevant to the training grant,
- Predoctorates or postdoctorates who were appointed to the research training grant.
For those trainees who were enrolled in the academic program, information about the duration of their research training and whether they finished their training in good standing should be included.
Peer reviewers will separately evaluate the recruitment and retention plan to enhance diversity after the overall score has been determined. Reviewers will examine the strategies to be used in the recruitment and retention of individuals from underrepresented groups. The review panel's evaluation will be included in an administrative note in the summary statement. The reviewers will evaluate the adequacy of the plan, past efforts at recruitment/outreach and proposed changes or expansion of past practices. The results of this evaluation will not be factored into the application priority score. If the recruitment and retention plan to enhance diversity is judged to be unacceptable, funding will be withheld until a revised plan (and report) that addresses the deficiencies is received. Staff within the NIH awarding component, with guidance from the appropriate national advisory committee or council as needed, will determine whether amended plans and reports submitted after the initial review are acceptable.
This Program Announcement requires all applicants to submit a recruitment and retention plan to enhance diversity. If an application is received without a plan, the application will be considered incomplete and will not be reviewed.
The NIH recognizes a unique and compelling need to promote diversity in the biomedical, behavioral, clinical and social sciences workforce. The NIH expects efforts to diversify the workforce to lead to the recruitment of the most talented researchers from all groups; to improve the quality of the educational and training environment; to balance and broaden the perspective in setting research priorities; to improve the ability to recruit subjects from diverse backgrounds into clinical research protocols; and to improve the nation's capacity to address and eliminate health disparities.
Accordingly, the NIH continues to encourage institutions to diversify their student and faculty populations and thus to increase the participation of individuals currently underrepresented in the biomedical, clinical, behavioral, and social sciences such as: individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds that have inhibited their ability to pursue a career in health-related research. Institutions are encouraged to identify candidates who will increase diversity on a national or institutional basis. The NIH is particularly interested in
encouraging the recruitment and retention of the following classes of candidates:
A. Individuals from racial and ethnic groups that have been shown by the National Science Foundation to be underrepresented in health-related sciences on a national basis (see http://www.nsf.gov/statistics/showpub.cfm?TopID=2&SubID=27) In addition, it is recognized that under-representation can vary from setting to setting, so individuals from racial or ethnic groups that can be convincingly demonstrated as underrepresented by the grantee institution should be encouraged to participate in this program.
B. Individuals with disabilities, who are defined as those with a physical or mental impairment that substantially limits one or more major life activities.
C. Individuals from disadvantaged backgrounds who are defined as:
1. Individuals who come from a family with an annual income below established low-income thresholds. These thresholds are based on family size, published by the U.S. Bureau of the Census; adjusted annually for changes in the Consumer Price Index; and adjusted by the Secretary for use in all health professions programs. The Secretary periodically publishes these income levels at http://aspe.hhs.gov/poverty/index.shtml. For individuals from low income backgrounds, the institution must be able to demonstrate that such candidates have qualified for Federal disadvantaged assistance or they have received any of the following student loans: Health Professional Student Loans (HPSL), Loans for Disadvantaged Student Program, or they have received scholarships from the U.S. Department of Health and Human Services under the Scholarship for Individuals with Exceptional Financial Need.
2. Individuals who come from a social, cultural, or educational environment such as that found in certain rural or inner-city environments that have demonstrably and recently directly inhibited the individual from obtaining the knowledge, skills, and abilities necessary to develop and participate in a research career. Recruitment and retention plans related to a disadvantaged background are most applicable to high school and perhaps undergraduate candidates, but would be more difficult to justify for individuals beyond that level of achievement.
PLAN FOR TRAINING IN THE RESPONSIBLE CONDUCT OF RESEARCH: The reviewers
will evaluate the plan for the instruction in the responsible conduct of
research (data management and record keeping, conflict-of-interest, responsible
authorship, scientific misconduct, use of human subjects and animals in
research). Institutional plans are appropriate. The rationale for the plan of
instruction must be provided. The activities described for training must be
required of trainees. The evaluation of the plan is not considered in
determining the priority score.
OTHER CONSIDERATIONS:
The following statements regarding human subjects and animal care and use are
printed in all T32 summary statements since it is undetermined as to whether
trainees will use human subjects or materials from human subjects or animals in
their individual projects.
Protection of human subjects: Prior to funding, a project that
involves human subjects must be reviewed and approved by the institutional
review board and certification submitted to the awarding institute. The project
must also conform to the NIH polices on data and safety monitoring and on the
inclusion of women, minorities, and children in study populations (and a
description of, and rationale for, the plans must be provided to the awarding
institute). (If appropriate, the application should address the inclusion of
Human Subjects, as well as the inclusion of Gender and Minorities, and the
inclusion of Children as Participants. This information can be found in the Human
Subjects Research section of the instructions for preparing a
PHS 398 Form (Revised 9/2004) application.
Vertebrate animals: Prior to funding, a project that utilizes
laboratory animals must be reviewed and approved by the Institutional Animal
Care and Use Committee and verification submitted to the awarding institute.
(If Vertebrate Animals are going to be used in the project, the application
should follow the specific instructions in the Vertebrate Animals section of
the instructions for preparing a
PHS 398 Form (Revised 9/2004) application.
Back to Top
Frequently Asked Questions
The following are commonly asked questions related to the T32 mechanism. For
additional questions and answers regarding the NIH T32 grant mechanism, see
NIH Research Training Opportunities: Frequently Asked Questions - NRSA Training
Grants.
1. Can an individual be appointed to a post-doctoral training position if he/she
has completed all requirements of the doctorate, but has not formally received
a diploma?
Yes, however, the NCI requires official documentation that the individual has
met all requirements for the doctoral degree. The appointment date on the T32
must be on or after the date citing that all doctoral requirements have been
completed.
2. Can a trainee be appointed to a T32 grant if he/she has applied for, but has
not yet received, a 'Green Card'?
No. Citizenship requirements must be met at the time of activation of a
training grant appointment.
3. How is the stipend level determined for the T32 trainee?
Stipends are approved by Congress and can change each fiscal year. There is one
stipend level for predoctorals and an escalating scale of stipends for
postdoctoral, depending upon whether they have 0, 1, 2, 3, 4, 5, 6, 7 or more
years of relevant experience after receiving the doctoral degree. Relevant
experience may include research (including research in industry), teaching,
residency, or clinical duties or other time spent full-time in a health-related
field. Consult the NCI Staff
Contacts or see the
NRSA stipends notices. Also, for your convenience, the NCI has provided
correct stipend levels to the year, month and day for the Fiscal Years
currently in effect:
FY2006 Stipend Levels (Excel
Spreadsheet) (PDF
File)
FY2005 Stipend Levels (Excel
Spreadsheet) (PDF
File)
FY2004 Stipend Levels (Excel
Spreadsheet) (PDF
File)
FY2003 Stipend Levels (Excel
Spreadsheet) (PDF
File)
4. Can a trainee be supported on an NIH research grant at the same time he/she is
receiving a stipend from a T32 grant?
No. Public Health Service funds may not be used to supplement an NRSA stipend.
Trainees are required to devote full-time effort to the training program. While
trainees may receive a separate salary from an NIH grant when employed for
services such as laboratory assistant, this must be on a limited part-time
basis (maximum of 20 hours per week) and may not interfere with, detract from,
or prolong the trainee's approved NRSA training program.
5. Can a competitive continuing application, with an inadequate minority
recruitment plan, be funded?
Yes, but only for one year. In order to receive full funding, the Principal
Investigator must resubmit a revised minority recruitment plan to the NCI, and
a Peer Review Committee must approve it. If, upon review, the minority
recruitment plan is found to be inadequate, the Principal Investigator is urged
to contact the NCI Program staff for guidance.
6. Can a T32 grant be awarded for less than five years?
Yes. While it is customary for the T32 to be awarded for five years, the Peer
Review Committee may recommend that the time of the award be reduced because of
inadequacies in the application.
7. Can the cost of recruiting trainees be charged to the T32 grant?
Yes. See the PHS Grants Policy
Statement for details.
8. How can I ensure that my grant application will be sent to the NCI?
To ensure that your grant application is sent to the NCI, attach a letter to
the face page of the application with that request. If it is cancer-related,
the Program Director will accept it for review. If it is not accepted at the
NCI it will be sent to a more appropriate Institute.
9. Are there instructions and guidance that can help PIs administer their grants?
See Manual for Administering Institiutional T32 National Research Service Award.
10. To what Study Section do I send my T32 application?
Instructions for sending an application can be found in the
T32 Program
Announcement. All applications are sent directly to the Center for Scientific
Review (CSR). CSR distributes applications to the appropriate Institutes (I)
and Centers (C). Each I/C has a special Study Section that reviews the T32s. A
peer-review group convened by the NCI Division of Extramural Activities will
review the T32 applications sent to the NCI.
11. What is the NCI policy for T32s on Training in the Responsible Conduct of
Research?
Every T32 application must include a section on the Training in the Responsible
Conduct of Research that is assessed for adequacy by the Peer Review Committee.
It is mandatory that every trainee complete this training.
12. Do T32 grants have pre-award cost authority?
Yes, but with restrictions. The
PHS Grants Policy Statement governs expenditure of funds for the T32
grant for all costs. However, stipends and tuition costs may not be charged to
the grant before the trainee's appointment is made.
13. The NCI, along with other institutes at the NIH, uses a formula to calculate
the allowable costs for tuition/fees/self-only health insurance for each
grantee. Should the applicant use this formula to request a budget?
No. The applicant should request full costs in the application. The NCI's
Grants Management Branch will apply the formula at the time of the award.
However, remember that if the T32 budget exceeds $500,000 in direct costs for
any year, the applicant must receive prior approval from the NCI Program
Director.
14. How does one go about requesting changes to the T32 grant once it is awarded?
The Principal Investigator should contact the NCI Grants Administration
official to determine the appropriate procedures to request post-award changes.
This also applies to any needs that require prior approval from the NCI. In
general, the PI should send a request that is signed by the PI and a business
official at the grantee institution. After receiving the request, the Grants
Administration official will consult with the NCI scientific program staff as
necessary to determine whether the request can be approved.
15. Can there be a change of distribution of pre- and post-doctoral trainees
after an award is made?
Yes. The change of trainees from one category to the other can occur with the
prior approval of the NCI Program Director. The Principal Investigator should
submit the request in writing and it should be co-signed by the Institutional
Business Official. The request should be sent to the NCI Program Director.
16. In a no-cost extension situation can a new trainee be appointed during this
period?
No. NCI policy prohibits such an appointment; however, a re-appointment of a
current trainee to the full extent of the remaining budget is possible. It is
NCI policy that pre-doctorals have a higher priority than post-doctorals if the
budget is limited during the no-cost extension phase because post-doctorals
have more flexibility to move elsewhere.
17. Does the T32 grant operate under Expanded Authority?
In NOT-OD-01-070
Revised Terms and Conditions for NIH Awards (released September 28,
2001, effective October 1, 2001) the authorities currently known as Expanded
Authorities will become standard terms and conditions for all NIH grant awards.
18. Must a trainee be appointed at the beginning of a budget period?
No. Trainees can be appointed for an entire 12-month training period at any
time during the budget period.
19. Does a trainee have to pay taxes for stipends received?
For information about taxes, see the Tax Liability information in the STIPEND
SUPPLEMENTATION, COMPENSATION AND OTHER INCOME section of the
T32 Program Announcement. This section of the Program Announcement
explains the requirements for all candidates.
20. Is a new Appointment Form required each year for each trainee supported by
the T32 grant?
Yes. A new Appointment
Form (PHS 2271) is required each year for each trainee. Each
appointment begins a new 12-month period.
21. When is a Termination Form required?
A Termination Form (PHS
416-7) is required immediately upon termination from the T32 grant.
Information on the Appointment and Termination forms must coincide. If a
trainee leaves prior to the originally planned appointment period, then an
amended appointment form must be submitted so the termination date matches the
end of the abbreviated appointment period, and the stipend must be pro-rated.
If a trainee takes a leave of absence, a
Termination Form (PHS 416-7) must be submitted. All forms must be sent
to the NCI Training Branch.
22. Is a payback agreement required for all newly appointed postdoctoral
trainees?
Yes. A Payback Agreement
(PHS 6031) is required for postdoctoral trainees who are newly
appointed to an NRSA T32 grant. A payback agreement is NOT required for
reappointment.
Back to Top
NCI Staff Contacts
For additional information regarding policies and/or guidance in preparing an application for the T32 Award, contact:
Dr. Lester S. Gorelic
Program Director
Telephone: (301) 496-8580
Fax: (301) 402-4472
E-mail: lg2h@nih.gov
Dr. Sonia B. Jakowlew
Program Director
Telephone: (301) 496-8580
Fax: (301) 402-4472
E-mail: jakowles@mail.nih.gov
Dr. Shannon M. Lemrow
Program Director
Telephone: (301) 496-8580
Fax: (301) 402-4472
E-mail: lemrows@mail.nih.gov
Ms. Nancy C. Lohrey, M.S., MT-ASCP
Program Director
Telephone: (301) 496-8580
Fax: (301) 402-4472
E-mail: Lohreyn@mail.nih.gov
Dr. Dorkina Myrick
Program Director
Telephone: (301) 496-8580
Fax: (301) 402-4472
E-mail: myrickd@mail.nih.gov
For information regarding review issues, contact:
Referral Officer
Division of Extramural Activities
Telephone: (301) 594-1403
Fax: (301) 402-0275
Back to Top
|
